adult head and neck tumors. Such tumors need to be approached systematically with an initial FNA, biopsy, or local resection, and with the patient's consent for a possible more radical resection, based on frozen section results.
TGF-Beta-1 Modulates Expression of VEGF and HGF in HNSCC
Carsten Thorn, MD (presenter) ; Karl Hoermann; Ramin Naim OBJECTIVE: Promoting angiogenesis is a key capability of most malignant tumors, leading to local growth and disease progression. Therapeutic targeting of angiogenesis has therefore become a promising new approach in cancer therapy. Beside the well described factors VEGF and HGF, TGF-beta is one of the most important factors linked with increased tumorangiogenesis. There are several different pathways of signals that can promote angiogenesis. One of the possibilities of modulating the activity of those pathways is by modulating the production of angiogenesis-modulating factors in surrounding cells. To examine this phenomenon, we switched off the production of TGF-beta-1 in different tumor cell lines and examined its effect on the production of VEGF and HGF. The aim of the study was to gain understanding in how head and neck carcinomas are able to benefit from increased levels of TGFbeta-1 to promote angiogenesis. METHOD: We used TGF-beta-1 Antisense RNA to block the TGF-1 production in UMSCC 11A, 22B and 14C. Incubation time was 48 and 72 hours. Afterwards we used ELISA to measure the concentration of VEGF and HGF in the supernatant of the cell cultures. RESULTS: After incubation time of only 48 hours, we observed a significant increase of HGF concentration. This effect was not stable over the next 48 hours. Looking at the VEGF expression, the 3 different cell lines showed different but characteristic patterns of expression that could be explained by their origin. Changing the incubation time or the concentration of incubated TGF-beta-1 Antisense RNA correlated in a significant way with the observed patterns of angiogenic factor expression. CONCLUSION: The results of this study show that TGFbeta-1 has definitely a modulating influence on the expression of some of the most important promoters of tumor-angiogenesis, and it therefore could be considered as a target for future therapeutic strategies.
The ENT Perspective in Sinus Lift
Mario Mantovani, MD (presenter); Sara Torretta, MD; Lorenzo Pignataro, MD OBJECTIVE: (Maxillary) sinus lift (SL) is a widespread procedure to rehabilitate the upper dental arch. Due to the involvement of the delicate maxillary sinus homeostasis, any preexisting physiopathologic impairment must be carefully excluded and, if possible, corrected to avoid unpleasant complications. Therefore, pre-operative ENT assessment may be necessary. METHOD: On the basis of a decennial personal experience, we here present our protocol adopted in order to evaluate patients' candidacy to SL, according the original settlement of the major ENT contraindications to SL, classified as presumably irreversible (PIEC) and potentially reversible (PREC), conceived by the senior author (MM) in 2001. RESULTS: PREC includes all the conditions possibly treatable by an adequate medical or surgical treatment, such as limited anatomic alteration of the maxillary drainage (septal deviation, concha bullosa, ostiomeatal complex obstruction); naso-sinusal inflammation (acute sinusitis, non-invasive mycotic sinusitis, chronic sinusitis substained by structural impairments, naso-sinusal polyposis groups I-IV according to Stammberger's classification); antro-ethmoidal foreign bodies; small oro-antral fistula; limited benign naso-sinusal neoplasms
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